Matches in Wikidata for { <http://www.wikidata.org/entity/Q64040916> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q64040916 description "clinical trial" @default.
- Q64040916 description "ensayu clínicu" @default.
- Q64040916 description "klinisch onderzoek" @default.
- Q64040916 description "клінічне випробування" @default.
- Q64040916 description "կլինիկական փորձարկում" @default.
- Q64040916 name "Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension" @default.
- Q64040916 type Item @default.
- Q64040916 label "Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension" @default.
- Q64040916 prefLabel "Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension" @default.
- Q64040916 P1050 Q64040916-232843D1-6DE7-492E-AC79-4613AF913433 @default.
- Q64040916 P1050 Q64040916-8D7372D6-E8D1-4D65-A2E6-AF01C177002A @default.
- Q64040916 P1132 Q64040916-4D8A6D6E-3EBA-433F-95B9-872FE0BC8062 @default.
- Q64040916 P1476 Q64040916-D6565D64-B41A-4994-9162-3B97A03B2082 @default.
- Q64040916 P17 Q64040916-93C6AC4D-64C2-45EC-B027-3814A7D63440 @default.
- Q64040916 P2899 Q64040916-A34B0DA5-685D-4688-84AA-7DF3590A9524 @default.
- Q64040916 P3098 Q64040916-847F831E-ABBD-44CD-9CFB-80BF71A379FB @default.
- Q64040916 P31 Q64040916-FE38A068-2C6A-486B-B31B-43C266891B76 @default.
- Q64040916 P4135 Q64040916-339563B0-C42C-4A20-AFD5-40297E07307E @default.
- Q64040916 P580 Q64040916-CE93FCB2-5BE1-445B-9B63-0829C3C9459B @default.
- Q64040916 P582 Q64040916-4D8592D8-C80D-4D19-B8EE-5B0D8CAC21E6 @default.
- Q64040916 P6099 Q64040916-5C976CF6-72F8-41D5-A1E0-AA26ABF98739 @default.
- Q64040916 P8363 Q64040916-DC4A739F-7DBE-4278-9B97-CD81C71E1232 @default.
- Q64040916 P1050 Q41861 @default.
- Q64040916 P1050 Q988405 @default.
- Q64040916 P1132 "+83" @default.
- Q64040916 P1476 "A Double Blind, Randomized, Placebo Controlled, Parallel Group, Dose-Titration Phase II Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Efficacy of an Anti-Angiotensin II Vaccine (CYT006-AngQb) in Patients With Mild to Moderate Essential Hypertension" @default.
- Q64040916 P17 Q39 @default.
- Q64040916 P2899 "+18" @default.
- Q64040916 P3098 "NCT00710372" @default.
- Q64040916 P31 Q30612 @default.
- Q64040916 P4135 "+69" @default.
- Q64040916 P580 "2008-06-01T00:00:00Z" @default.
- Q64040916 P582 "2009-07-01T00:00:00Z" @default.
- Q64040916 P6099 Q42824440 @default.
- Q64040916 P8363 Q78089383 @default.